Hao Xu

机构：Zhejiang Chinese Medical University, Hubei University of Medicine, China National Pharmaceutical Group Corporation (China), Dongfeng General Hospital · ORCID：0000-0003-4444-8408

发表论文 12 篇 · 总被引 219 次 · h-index 7

代表论文

• Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review (2023 · Biomedicine & Pharmacotherapy · 被引 74)
• Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction (2023 · Frontiers in Pharmacology · 被引 32)
• Linggui Zhugan decoction delays ventricular remodeling in rats with chronic heart failure after myocardial infarction through the Wnt/β-catenin signaling pathway (2023 · Phytomedicine · 被引 30)
• Ferrostatin-1 improves BMSC survival by inhibiting ferroptosis (2023 · Archives of Biochemistry and Biophysics · 被引 26)
• Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation (2024 · Inflammation · 被引 24)
• The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus (2024 · Frontiers in Immunology · 被引 9)